← 返回產品資料庫
羅氏抗上皮生長因子受體(3C6)一級抗體
🩺 醫材Roche CONFIRMTM anti-Epidermal Growth Factor Receptor (3C6) Primary Antibody
衛署醫器輸字第020372號
醫材分類
第 2 等級
- B.1860免疫病理組織化學試劑與套組
醫器規格
Roche CONFIRMTM anti-Epidermal Growth Factor Receptor (3C6) Primary AntibodyCatalog number 790-2988
限制項目
輸 入
適應症
用於直接對抗人類抗上皮生長因子受體蛋白(分子量為170kD)。此抗體也可辨識分子量為145kD的突變III型。
醫材資訊
- 主成分
- Reagents Provided\nCONFIRM anti-EGFR (3C6) contains sufficient reagent for 50 test. 1-5 ml dispenser of CONFIRM anti-EGFR (3C6) contains approximately 5μg of a mouse monoclonal antibody directed against EGFR present in tissue. The antibody is diluted in Tris buffered saline containing carrier protein and preservative.\nTotal protein concentration of the reagent is approximately 3 mg/ml.
- 製造商
- VENTANA MEDICAL SYSTEMS, INC
- 製造國
- US
- 申請商
- 台灣羅氏醫療診斷設備股份有限公司
- 有效日期
- 2029/09/09
- 發證日期
- 2009/09/09
供應藥局
目前尚無登錄供應此品項的藥局資料。